Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP414496.RA4Exfg4r_wJc6BiSzIxvHue-Wfcy3CGoc3Q_5_Gv023o130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP414496.RA4Exfg4r_wJc6BiSzIxvHue-Wfcy3CGoc3Q_5_Gv023o130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP414496.RA4Exfg4r_wJc6BiSzIxvHue-Wfcy3CGoc3Q_5_Gv023o130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP414496.RA4Exfg4r_wJc6BiSzIxvHue-Wfcy3CGoc3Q_5_Gv023o130_provenance.
- befree-20150227 importedOn "2015-02-27" NP414496.RA4Exfg4r_wJc6BiSzIxvHue-Wfcy3CGoc3Q_5_Gv023o130_provenance.
- NP414496.RA4Exfg4r_wJc6BiSzIxvHue-Wfcy3CGoc3Q_5_Gv023o130_assertion wasGeneratedBy ECO_0000203 NP414496.RA4Exfg4r_wJc6BiSzIxvHue-Wfcy3CGoc3Q_5_Gv023o130_provenance.
- NP414496.RA4Exfg4r_wJc6BiSzIxvHue-Wfcy3CGoc3Q_5_Gv023o130_assertion wasDerivedFrom befree-20150227 NP414496.RA4Exfg4r_wJc6BiSzIxvHue-Wfcy3CGoc3Q_5_Gv023o130_provenance.
- NP414496.RA4Exfg4r_wJc6BiSzIxvHue-Wfcy3CGoc3Q_5_Gv023o130_assertion SIO_000772 20447716 NP414496.RA4Exfg4r_wJc6BiSzIxvHue-Wfcy3CGoc3Q_5_Gv023o130_provenance.
- NP414496.RA4Exfg4r_wJc6BiSzIxvHue-Wfcy3CGoc3Q_5_Gv023o130_assertion evidence source_evidence_literature NP414496.RA4Exfg4r_wJc6BiSzIxvHue-Wfcy3CGoc3Q_5_Gv023o130_provenance.
- NP414496.RA4Exfg4r_wJc6BiSzIxvHue-Wfcy3CGoc3Q_5_Gv023o130_assertion description "[Sorafenib induces the suppression of collagen accumulation and HSC growth warranting the use of sorafenib as a potential therapeutic agent in the treatment of liver fibrosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP414496.RA4Exfg4r_wJc6BiSzIxvHue-Wfcy3CGoc3Q_5_Gv023o130_provenance.